In AD cases, s-ICAM-1 levels raise in both blood and CSF, mirror the upsurges in transmembrane ICAM-1 holoprotein, positively correlate with illness severity [90,91,95], and partake in BBB’s dysfunction thus advancing immune cells infiltration into the CNS and hence neuroinflammation. This evidence concerns the gene ICAM1 and Alzheimer disease.